Climb Bio, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CLYM Nasdaq 2836 climbbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Climb Bio, Inc.

Climb Bio to Present at Upcoming Investor Conferences - Feb 5th, 2026 5:00 am
Climb Bio, Inc. (NASDAQ:CLYM) Shares Could Be 45% Below Their Intrinsic Value Estimate - Jan 24th, 2026 7:18 am
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 - Jan 8th, 2026 5:00 am
H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio’s (CLYM) Budoprutug Across Clinical Tracks - Dec 31st, 2025 9:13 am
Here's Why We're Watching Climb Bio's (NASDAQ:CLYM) Cash Burn Situation - Dec 28th, 2025 7:11 am
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Nov 25th, 2025 5:00 am
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Nov 6th, 2025 5:01 am
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential - Oct 31st, 2025 3:42 am
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy - Oct 21st, 2025 5:00 am
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 - Oct 17th, 2025 5:00 am
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer - Oct 1st, 2025 5:00 am
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN - Sep 29th, 2025 5:00 am
Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year? - Sep 11th, 2025 7:40 am
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025 - Sep 4th, 2025 5:00 am
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross - Sep 3rd, 2025 7:55 am
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences - Aug 25th, 2025 12:41 pm
Climb Bio to Present at Upcoming September 2025 Investor Conferences - Aug 25th, 2025 5:00 am
Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year? - Aug 20th, 2025 7:40 am
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors - Aug 19th, 2025 6:00 am
Climb Bio, Inc. (NASDAQ:CLYM) surges 12%; private equity firms who own 54% shares profited along with institutions - Aug 17th, 2025 8:21 am